ArticleOncotarget2017

IGF-1R tyrosine kinase inhibitors and Vitamin K1 enhance the antitumor effects of Regorafenib in HCC cell lines.

Maria Grazia Refolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.